Impact of Prior Malignancies on Outcome of Colorectal Cancer; Revisiting Clinical Trial Eligibility Criteria

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6074-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P2.01-46 Investigating the Effects of Prior Malignancy on NSCLC Trial Eligibility

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Impact of Psychiatric Utilisation Prior to Cancer Diagnosis on Survival of Solid Organ Malignancies

British Journal of Cancer
Cancer ResearchOncology
2019English

Impact of HPV Infection on the Clinical Outcome of P-Cair Trial in Head and Neck Cancer

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2010English

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

Journal of Cancer
Oncology
2012English

Chemotherapy Outcome Predictive Effectiveness by the Oncogramme: Pilot Trial on Stage-Iv Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Comment on ‘Impact of UK Medical Eligibility Criteria Implementation on Prescribing of Combined Hormonal Contraceptives’: Author's Response

Journal of Family Planning and Reproductive Health Care
2013English

Reporting of Eligibility Criteria of Randomised Trials: Cohort Study Comparing Trial Protocols With Subsequent Articles

BMJ
2011English

MA14.10 QTc Interval-Prolonging Medications in Lung Cancer: Implications for Clinical Trial Eligibility and Routine Clinical Care

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Eligibility Criteria for Ambulatory EVAR

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy